HealthEquity, Inc. (HQY)

HealthEquity Cash Flow Statement

Financials in millions USD. Fiscal year is February - January.

Year	2023	2022	2021	2020	2019
Net Income	55.71	-26.14	-44.29	8.83	39.66
Depreciation & Amortization	153.08	161.2	137.19	115.9	55.35
Share-Based Compensation	77.15	62.61	52.75	42.86	39.84
Other Operating Activities	-43.12	-47.02	-4.65	14.02	-29.85
Operating Cash Flow	242.83	150.65	141	181.62	105.01
Operating Cash Flow Growth	61.19%	6.85%	-22.37%	72.95%	-7.42%
Capital Expenditures	-42.82	-48.54	-71.62	-64.59	-32.94
Acquisitions	-3.26	-70.58	-570	-32.37	-1,644.58
Change in Investments	0	0	2.37	0	-53.85
Other Investing Activities	-	-	-	-	-9.13
Investing Cash Flow	-46.07	-119.13	-639.25	-96.96	-1,740.49
Share Issuance / Repurchase	6.47	6.68	466.39	295.35	469.84
Debt Issued / Paid	-54.38	-8.75	-65.05	-239.06	1,212
Other Financing Activities	0.87	-0.6	-6.49	-3.86	-215.79
Financing Cash Flow	-47.04	-2.67	394.86	52.42	1,466
Net Cash Flow	149.71	28.85	-103.39	137.08	-169.75
Free Cash Flow	200.01	102.11	69.38	117.03	72.07
Free Cash Flow Growth	95.88%	47.17%	-40.71%	62.38%	-27.62%
Free Cash Flow Margin	20.01%	11.85%	9.17%	15.95%	13.55%
Free Cash Flow Per Share	2.34	1.21	0.83	1.58	1.07

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).